EODData

MEMBERSHIP REGISTER LOG IN

FRA, 0GT: STOKE THERAPEUT.DL-001

30 Sep 2025
LAST:

20.80

CHANGE:
 0.40		OPEN:
20.80		HIGH:
20.80		ASK:
0.00		VOLUME:
0
CHG(%):
1.96		PREV:
20.40		LOW:
20.80		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
30 Sep 2520.8020.8020.8020.800
29 Sep 2520.4020.4020.4020.4035
26 Sep 2519.4019.4019.4019.4035
25 Sep 2519.2019.2019.1019.1035
24 Sep 2518.9019.5018.9019.5016
23 Sep 2519.1019.2019.1019.2050
22 Sep 2519.3019.3019.2019.20100
19 Sep 2519.7019.7019.7019.7050
18 Sep 2519.0019.0019.0019.0050
17 Sep 2519.2019.2019.2019.2050

COMPANY PROFILE

Name:STOKE THERAPEUT.DL-001
About:Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational new medicine for the treatment of Dravet syndrome is being evaluated in phase I/II clinical trials. The company also develops programs focused on various targets, including haploinsufficiency diseases of the central nervous system and eye. It has a license and collaboration with Biogen Inc. for the development and commercialization of zorevunersen medicine for the treatment of Dravet syndrome; and Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of genetic neurodevelopmental diseases. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:45 Wiggins Avenue, Bedford, MA, United States, 01730
Website:https://www.stoketherapeutics.com
ISIN:US86150R1077
LEI:549300RD25SS2DIJHJ67

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:22.43
Price to Book:3.20
Price to Sales:4.63
EBITDA:42.27M
Shares:54.8M
Market Cap:1.14B

TECHNICAL INDICATORS

MA5:19.84
MA10:19.55
MA20:19.05
MA50:15.77
MA100:12.62
MA200:10.59
STO9:100.00
STO14:100.00
RSI14:65.00
MTM14:1.40
ROC14:0.07
ATR:0.48
Week High:20.80
Week Low:18.90
Month High:20.80
Month Low:16.60
Year High:20.80
Year Low:5.18
Volatility:6.70